Clear Cell Carcinoma clinical trials at UCSF
1 research study open to eligible people
Clear cell carcinoma is a rare type of cancer. UCSF is exploring new treatment options through clinical trials. One of these trials is investigating the use of Vudalimab in patients with advanced gynecologic and genitourinary cancers.
Showing trials for
XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
open to eligible people ages 18 years and up
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in patients with selected advanced gynecologic and genitourinary malignancies.
San Francisco, California and other locations
Last updated: